
Bath & Body Works, Inc. (NYSE:BBWI) on Thursday reported better-than-expected third-quarter results. The company raised its full-year sales forecast but issued cautious fourth-quarter guidance.
Adjusted diluted earnings of 26 cents per share beat the 12-cent consensus estimate, but declined compared to 35 cents a year earlier. Net sales fell 1% year over year to $1.58 billion but topped the $1.55 billion estimate.
For the fourth quarter, Bath & Body Works expects diluted earnings of $1.41 to $1.61 per share, below the $1.71 analyst estimate. Revenue is projected at $2.574 billion to $2.670 billion, compared with the $2.666 billion consensus estimate.
Bath & Body Works lowered its fiscal 2026 GAAP earnings forecast to between $3.09 and $3.29 per share. Its previous outlook called for $3.13 to $3.33 per share. Analysts expect $2.96 per share.
The company maintained its adjusted earnings forecast of $2.60 to $2.80 per share, compared with the estimate of $2.74. It raised its fiscal 2026 sales forecast to between $7.043 billion and $7.138 billion. Its previous outlook ranged from $6.999 billion to $7.109 billion. Analysts expect $7.105 billion.
Daniel Heaf, chief executive officer of Bath & Body Works, said, “Our third quarter results exceeded our sales and adjusted earnings per share guidance, and marks encouraging progress in our Consumer First Formula. One year after introducing this strategy, we are seeing our actions translate into results across product, brand, and marketplace.”
Bath & Body Works shares rose 1.8% to trade at $19.04 on Friday.
These analysts made changes to their price targets on Bath & Body Works following earnings announcement.
Considering buying BBWI stock? Here’s what analysts think:
Photo via Shutterstock